Helmy Eltoukhy, PhD, CEO founder of Guardant Health (Nasdaq: GH)
Helmy is an entrepreneur and biotech pioneer. He holds a PhD, MS, and BS in EE from Stanford. During his Stanford doctoral studies, he developed the first semiconductor sequencing platform and first base-calling algorithm for next-gen sequencing. In 2007, he co-founded Avantome to commercialize semiconductor sequencing and sold the company to Illumina in 2008. In 2012, Eltoukhy and AmirAli Talasaz co-founded Guardant Health, established to "forge a new frontier" in cancer detection and treatment using AI. Guardant went public on the NASDAQ in 2018, and was the first Pear VC's portfolio company to IPO.
Apply to pitch here: https://forms.gle/Hrsutn2WZGqN8Rsj7
Join us for an inspiring story and advice he has for aspiring and current entrepreneurs!
MORE PEAR VC EVENTS HERE www.pear.vc/speakers